Fig. 10From: Transcriptome-wide map of N6-methyladenosine (m6A) profiling in coronary artery disease (CAD) with clopidogrel resistanceValidation of the m6A-enriched genes and candidate loci. A Validation of the m6A-enriched genes as indicated by m6A-immunoprecipitation (IP)-qPCR. B Validation of the expression levels of candidate mRNAs, lncRNAs, and circRNAs as determined by RT-qPCRBack to article page